Agreement and Plan of Merger by and Among Horizon Pharma Plc, Misneach Corporation and Raptor Pharmaceutical Corp. Dated as of September 12, 2016 (September 12th, 2016)
THIS AGREEMENT AND PLAN OF MERGER (this Agreement) is made and entered into as of September 12, 2016 by and among Horizon Pharma plc, a public limited company organized under the laws of Ireland (Parent), Misneach Corporation, a Delaware corporation and an indirect wholly owned subsidiary of Parent (Merger Sub), and Raptor Pharmaceutical Corp., a Delaware corporation (the Company). Certain capitalized terms used in this Agreement are defined in Article X.
Executive Employment Agreement (November 5th, 2015)
This Executive Employment Agreement (the "Agreement") is entered into as of June 19, 2015, by and between Ashley Gould ("Executive") and Raptor Pharmaceutical Corp. (the "Company").
Amended and Restated Executive Employment Agreement (July 8th, 2014)
This Amended and Restated Executive Employment Agreement (the Agreement) is entered into as of July 7, 2014 (the Effective Date), by and between Julie Anne Smith (Executive) and Raptor Pharmaceutical Corp. (the Company).
Second Amendment to Manufacturing Services Agreement Between Patheon Pharmaceuticals Inc., and Raptor Pharmaceuticals Inc. (August 9th, 2013)
Background: Patheon Pharmaceuticals Inc., ("Patheon") and Raptor Pharmaceuticals Inc., (formerly known as Raptor Therapeutics, Inc.), ("Raptor") entered into a Manufacturing Services Agreement dated November 15, 2010, as amended on April 5, 2012 (the "Agreement"). Patheon and Raptor wish to further amend the Agreement to add Raptor Pharmaceuticals Europe B.V., a wholly owned subsidiary of RPTP European Holdings C.V. (a wholly-owned subsidiary of Raptor) as an additional party to the Agreement and to update the Pricing in Schedule B.
Employment Agreement (September 12th, 2012)
This Employment Agreement (this Agreement) is entered into as of this 10 day of September, 2012 (the Effective Date) by and between Raptor Therapeutics Inc., a Delaware corporation with its principal offices located at 9 Commercial Blvd., Suite 200, Novato, California 94949 (the Company), and Julie Smith, a resident of Clark County, Nevada (Employee).
Contract (January 12th, 2004)
EXHIBIT 4.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of January 8, 2004, among Axonyx, Inc., a Nevada corporation (the "Company"), and the purchasers identified on the signature pages hereto (each a "Purchaser" and collectively the "Purchasers"); and WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act (as defined below), and Rule 506 promulgated thereunder, the Company desires to issue and sell to the Purchasers, and each Purchaser, severally and not jointly, desires to purchase from the Company in the aggregate, up to $50,000,000 of the Company's Common Stock and certain Warrants, as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, th